Repligen Corporation ( RGEN) - Key Metrics

RGEN Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $3.62 $0.09 $0.58 $0.49
2026Q1 $3.45 $0.15 $0.50 $0.41
2025Q4 $3.50 $0.24 $0.45 $0.30
2025Q3 $3.36 $0.27 $0.86 $0.76
2025Q2 $3.25 $0.26 $0.51 $0.37

RGEN Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 379
2026Q1 0% 196.37
2025Q4 0% 178.11
2025Q3 0% 123.77
2025Q2 0% 119.60

RGEN Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.36% 0%
2026Q1 0.35% 0%
2025Q4 0.18% 0%
2025Q3 0.57% 0%
2025Q2 0.30% 0%

RGEN

Price: $178.20

52 week price:
100.99
198.87

Earnings Per Share: 0.73 USD

P/E Ratio: 201.45

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 633600

Ebitda: 2.7 million

Market Capitalization: 9.4 billion

Links: